- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06317883
Childhood Obesity Risk Assessment Longitudinal Study (CORALS)
Longitudinal Study To Determine The Risk Factors Associated With Childhood Obesity
Childhood obesity is a major public health problem worldwide. Europe has a high prevalence of obesity, which is accentuated in Mediterranean countries. Spain has a high prevalence of both overweight (percentage: 21.5 in boys and 22.2 in girls) and obesity (percentage: 10.6 in boys and 11.8 in girls) in children aged 6-9 years.
From childhood, obesity is associated with an increased risk of diseases such as insulin resistance, type 2 diabetes, hypertension, metabolic syndrome, musculoskeletal problems, sleep disorders and mental health problems. Obesity is a complex, multi-causal problem involving individual risk factors such as behavior and genetics. Behavioral factors include diet, physical activity, sedentary lifestyle, sleep, and others. It is therefore important to study each of the individual risk factors for obesity. There are few large sample studies in European/Spanish children and no longitudinal studies estimating the incidence of obesity in preschool children based on exposure to different risk factors, considering not only the effect of food consumption but also dietary habits and patterns.
The aim of the present study is to identify risk factors for childhood obesity through long-term longitudinal follow-up.
Study Overview
Status
Conditions
Detailed Description
This is a longitudinal, multi-centre prospective cohort study of children aged 3-6 years with annual data collection for an average follow-up of 10 years.
The main objective of the present study is to identify risk factors for childhood obesity through long-term longitudinal follow-up. At least 2,214 participants are required.
The specific objectives are as follows:
- Assess the associations between perinatal risk factors, socioeconomic, cultural and environmental factors and the risk of developing obesity and its comorbidities.
- Assess the associations between lifestyles (diet, beverage consumption, physical activity, sedentary lifestyle, sleep) and the risk of developing obesity and its comorbidities.
- Evaluate the association between genetic polymorphisms, metabolomic and metagenomic profiles (determined by omics techniques) and the development of obesity and its comorbidities.
Study design
The selection visit includes:
A) The administration of a face-to-face questionnaire to check eligibility criteria. Only if the participant is eligible the screening visit will proceed to b).
B) Explanation and clarification of any doubts about the study, delivery of the study information sheet to the participant and completion of the informed consent form signed by both parents (essential for inclusion in the study).
C) The family will be provided with a 3-day prospective food record (2 working days and 1 weekend day), the general data collection booklet and the following questionnaires: adherence of the primary tutor to the Mediterranean diet, dietary behavior, psychosocial, active lifestyle, sedentary behavior and sleep patterns. These questionnaires are to be returned at the next visit.
D) Instructions and bottles for collecting biological samples are given.
Inclusion visit includes:
- Review of the 3-day food record and all questionnaires from the selection visit.
- Once the inclusion and exclusion criteria have been evaluated, the participant will be included in the study if all the requirements are met. Then, the next step will be taken.
- Completion of the 14-point Mediterranean diet adherence questionnaire (to be completed by the primary tutor), baseline questionnaire (height, weight, waist, bioimpedance, blood pressure, child's active lifestyle and Mediterranean diet adherence) and the food and drink frequency questionnaire.
- Performing a speech fluency test and a fitness assessment examination.
- Collection of blood, urine, and stools samples.
- If the participant has an odd-numbered ID, an accelerometer is provided to be used for 7 consecutive days. Collected data must be recorded in a diary.
After the inclusion visit, the participant will undergo two types of follow-up visits in which the following evaluations will be made:
Follow-up visits - Years 01, 02, 04, 06, 07, 08 and 09
- Baseline questionnaire without collecting biological samples
- Food frequency questionnaire
- 14-point Mediterranean diet adherence questionnaire
Follow-up visits - Years 03, 05 and 10 Completion of all questionnaires and determinations corresponding to the inclusion visit.
A window of ±3 months of the corresponding follow-up year since the inclusion visit is allowed.
Justification: The results of this study could help to understand and act on the key determinant factors of the epidemic of overweight and obesity in children.
Long-term follow-up of a large cohort is necessary to develop strategies to combat the serious consequences that overweight and obesity cause on the spanish public health system. This is an important objective and a clear public health priority, since it addresses both the main epidemic of our time (childhood overweight/obesity) as the main cause of healthcare expenditure at increasingly younger ages that makes the current healthcare system unviable (chronic diseases).
The project involves a large number of children from early childhood and follows them over time, covering the key ages for the establishment of dietary habits, lifestyles and adipose rebound. The study can allow the transfer and translation to the general population and the integration of epidemiological, clinical and basic aspects in the proposed research.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Barcelona, Spain, 08003
- Institut Hospital del Mar d'Investigacions Mèdiques
-
Córdoba, Spain, 14071
- University of Cordoba
-
Tarragona, Spain, 43002
- Rovira i Virgili University
-
Valencia, Spain, 46010
- University of Valencia
-
Zaragoza, Spain, 50018
- University of Zaragoza
-
-
La Coruña
-
Santiago De Compostela, La Coruña, Spain, 15782
- University of Santiago de Compostela
-
-
Navarra
-
Pamplona, Navarra, Spain, 31009
- University of Navarra
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Children aged 3 to 6 years.
- Compliance with the 3-day food consumption record, the free time physical activity questionnaire and attendance at the scheduled inclusion visit together with the delivery of the signed informed consent.
Exclusion Criteria:
- Children from families with difficulties in participating or complying with the study protocol, as well as difficulties with comprehension, language, or unstable domicile.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
CORALS
Children aged 3-6 years
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of dietary intake and habits
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
The habitual intake of the child is assessed by using the food and drink frequency questionnaire and the 14-point Mediterranean diet adherence questionnaire.
In addition, a food behaviour questionnaire is administered to the child's parents or primary caregiver.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Assessment of physical activity, sedentary behavior and sleep pattern
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Sedentary activities are assessed by means of an ad hoc questionnaire on the time children spend watching television, using computers, cell phones, video games and consoles, as well as their sleep patterns.
Likewise, physical activity is assessed by (1) an ad hoc questionnaire to determine the active lifestyle of the children and (2) an accelerometries (half of the participants).
|
0, 3, 5 and 10 years since the selection visit.
|
Early risk factors
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
The parents of the children are asked to fill out a general questionnaire that request information regarding: personal and family history related to pregnancy, diseases, lifestyle, toxic habits, weight gain, lifestyle, toxic habits, and others.
|
0, 3, 5 and 10 years since the selection visit.
|
Body composition: Height
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Height in centimeters is measured with the SECA 213 precision measuring instrument on an annual basis.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Body composition: Weight
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Weight in grams is measured by the precision weighing scale model Tanita 780PMA on an annual basis.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Body composition: Body mass index
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Body mass index in kilograms per square meter is calculated on an annual basis.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Body composition: Waist circumference
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Waist circumference in centimeters is measured with a SECA 201 precision measuring tape on an annual basis.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Psychosocial and neuropsychological behavioral assessment
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Strengths and Difficulties Questionnaire (SDQ), an internationally recognized and validated questionnaire is used to assess the general behavior. The questionnaire is to be answered by the parents/tutor on an individual basis, focusing on the behavior of his/her son/daughter during the last 6 months. This questionnaire covers emotional symptoms, conduct problems, hyperactivity-inattention, peer problems, and prosocial behavior. The SDQ contains 5 subscales (4 dysadaptive and 1 adaptive [prosocial scale]). Each has a range of 0 to 10 points. The SDQ score range is 0-40 points (excluding the prosocial scale), with 0 being considered normality. |
0, 3, 5 and 10 years since the selection visit.
|
Verbal fluency
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Normative data from phonological and semantic verbal fluency tests (VFT) in Spanish-speaking pediatric populations is followed to assess verbal fluency, one of the most sensitive indicators of cognitive development, especially executive function.
|
0, 3, 5 and 10 years since the selection visit.
|
Muscular strength
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Muscle strength is assessed by measuring both hand grip strength in kilograms and lower body explosive strength - a long jump with the feet together- in centimeters.
|
0, 3, 5 and 10 years since the selection visit.
|
Cardiorespiratory endurance
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Cardiorespiratory endurance is assessed in minutes by using the Course Navette test.
The number of completed series is recorded.
|
0, 3, 5 and 10 years since the selection visit.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Association between genetic polymorphisms, metabolomic and metagenomic profiles with the development of obesity.
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Aliquots of plasma, serum, and leukocyte layer are to be stored for DNA isolation for genetic/epigenetic analysis to investigate genetic, metabolomic, and epigenetic associations with the development of obesity.
|
0, 3, 5 and 10 years since the selection visit.
|
Body composition: Waist height
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Waist height in centimeters is measured on an annual basis.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Body composition: Fat mass
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Fat mass both in kilograms and in percentage is measured on an annual basis.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Body composition: Fat mass index
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Fat mass index in kilograms per square meter is calculated on an annual basis.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Body composition: Fat-free mass
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Fat-free mass in kilograms is measured on an annual basis.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Body composition: Total body water
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Total body water both in kilograms and in percentage is measured on an annual basis.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Systolic blood pressure measurement
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
On an annual basis, the systolic blood pressure is measured in mmHg in triplicate in order to obtain an average value.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Diastolic blood pressure measurement
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
On an annual basis, the diastolic blood pressure is measured in mmHg in triplicate in order to obtain an average value.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Heart rate measurement
Time Frame: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
On an annual basis, the heart rate is measured in beats per minute in triplicate in order to obtain an average value.
|
0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 years since the selection visit.
|
Hematological analysis: Hemoglobine
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Hemoglobin levels are determined in grams per deciliter on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Hematocrite
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Hematocrite levels are determined in percentage on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Erythrocytes
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Erythrocytes count is measured in 10e06 units per microliter on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Mean corpuscular volume
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Mean corpuscular volume is measured in femtoliters on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Mean corpuscular hemoglobin
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Mean corpuscular hemoglobine is measured in picograms on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Mean corpuscular hemoglobin concentration
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Mean corpuscular hemoglobine concentration is measured in grams per deciliter on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Red cell blood distribution width
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Red cell blood distribution width is determined in percentage on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: White blood cells
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
White blood cells count is measured in 10e03 units per microliter on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Neutrophils
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Neutrophils count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Lymphocytes
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Lymphocytes count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Monocytes
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Monocytes count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Eosinophils
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Eosinophils count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Basophiles
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Basophiles count is measured both in 10e03 units per microliter and in percentage on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Platelets
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Platelets count is measured in 10e03 units per microliter on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Hematological analysis: Mean platelet volume
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Mean platelet volume is measured in femtoliters on an individual basis.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Glucose
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Glucose is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Bilirubin
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Total bilirubin is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Creatinine
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Creatinine is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Urate
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Urate is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Urea
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Urea is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Total protein
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Total protein is measured both in grams per deciliter and in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Aspartate aminotransferase
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Aspartate aminotransferase is measured in international units per liter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Alanine aminotransferase
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Alanine aminotransferase is measured in international units per liter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Gamma-glutamyl transferase
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Gamma-glutamyl transferase is measured in international units per liter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Alkaline phosphatase
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Alkaline phosphatase is measured in international units per liter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Total cholesterol
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Total cholesterol is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: High density lipoproteins
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
High density lipoproteins (HDL) are measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Non-HDL cholesterol
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Non-HDL cholesterol levels are calculated in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Low density lipoproteins
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Low density lipoproteins (LDL) are measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Apolipoprotein A1
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Apolipoprotein A1 is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Apolipoprotein B
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Apolipoprotein B is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Calcium
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Calcium is measured both in milligrams per deciliter and in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Potassium
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Potassium is measured both in millimoles per liter and in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Sodium
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Sodium is measured in millimoles per liter, in milliequivalents per liter and in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Phosphorus
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Phosphorus is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Iron
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Iron is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Magnesium
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Magnesium is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Zinc
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Zinc is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Insulin
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Insulin is measured both in micro international units per liter and in picograms per milliliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Insulin resistance
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index is used to estimate insulin resistance.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: C-reactive protein
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
C-reactive protein is measured in milligrams per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Tumor necrosis factor alpha
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Tumor necrosis factor alpha is measured in picograms per deciliter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Adiponectin
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Adiponectin is measured in milligrams per liter on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Energy
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Energy is determined in kilocalories on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Carbohydrates
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Carbohydrates are measured in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Sugars
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Sugars are measured in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Fiber
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Fibers are measured in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Polysaccharides
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Polysaccharides are measured in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Total fat
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Total fat is measured in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Saturated fatty acids
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Saturated fatty acids are measured in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Monounsaturated fatty acids
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Monounsaturated fatty acids are measured in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Polyunsaturated fatty acids
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Polyunsaturated fatty acids are measured in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin B1
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin B1 is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin B2
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin B2 is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin B3
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin B3 is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin B6
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin B6 is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin B9
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin B9 is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin B12
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin B12 is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin C
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin C is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin A
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin A is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin D
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin D is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Vitamin E
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Vitamin E is measured in milligrams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Carotenes
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Carotenes are measured in micrograms on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Retinol
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Retinol is measured in micrograms on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Biochemical analysis: Water
Time Frame: 0, 3, 5 and 10 years since the selection visit.
|
Water is measured in grams on an individual basis.
Analysis performed in plasma.
|
0, 3, 5 and 10 years since the selection visit.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Mercedes Gil, Universidad de Córdoba
- Principal Investigator: Nancy E Babio, University Rovira i Virgili
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CORALS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child Obesity
-
Northwell HealthEnrolling by invitationChild Obesity | Child Nutrition Disorders | Child OvernutritionUnited States
-
University of CopenhagenNovo Nordisk A/S; University of Southern Denmark; Danish Research Centre for... and other collaboratorsNot yet recruitingChild Behavior | Child Development | Child Obesity | Sleep DurationDenmark
-
Aarhus University HospitalUniversity of Aarhus; Steno Diabetes Center Copenhagen; Steno Diabetes Center... and other collaboratorsRecruitingChild Behavior | Child Health | Child Obesity | Physical InactivityDenmark
-
Yale UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedParental Stress | Child Obesity | Parent and Child Stress | Parental and Child ObesityUnited States
-
Inter-American Development BankFundación Saldarriaga Concha; Instituto Departamental de Salud de Nariño; Ministerio...UnknownChild Obesity | Malnutrition, Child | Exclusive Breast Feeding
-
University of California, San FranciscoRecruitingChild Development | Child ObesityUnited States
-
University of Illinois at Urbana-ChampaignNational Institutes of Health (NIH); United States Department of Agriculture... and other collaboratorsActive, not recruitingChild, Only | Child Obesity
-
University of FloridaUnited States Department of Agriculture (USDA)CompletedCognitive Change | Parent-Child Relations | Parenting | Parents | Child Behavior | Healthy Lifestyle | Home Environment Related Disease | Child ObesityUnited States
-
Rutgers, The State University of New JerseyUnited States Department of Agriculture (USDA)RecruitingCognitive Change | Parent-Child Relations | Parenting | Parents | Child Behavior | Healthy Lifestyle | Home Environment Related Disease | Child ObesityUnited States
-
Lund UniversityRegion Skane; ForteCompleted